Study of CGC-11047 (PG-11047) in Subjects With Advanced Refractory Solid Tumors

NCT00705653 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
46
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Progen Pharmaceuticals